Because HEY2 expression was elevated in the follow-up biopsies compared with that in BCC debulk tissue, we next assessed the protein levels of NICD and HEY2 in the superficial debulk tumor, deep debulk tumor, and follow-up biopsies. The gene discussed is HEY2; the disease is skin basal cell carcinoma.